Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AZN · against 1,216 other Healthcare companies
Ranked #433 of 1,217 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including AZN · Click a bar to see the companies
Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | AZN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 8.6% | 6.1% | 58% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 45.3% | 9.7% | 75% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 9.8% | 5.8% | 62% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 433 | 1.86T KRW (≈$1.3B) | 64 | 43 | |
| 433 | 12.9B HKD (≈$1.7B) | 64 | 83 | |
| 433 | 7.5B CNY (≈$1.1B) | 64 | 82 | |
| 433 | 327.3B CNY (≈$45.8B) | 64 | 75 | |
| 433 | 285.2B USD | 64 | 63 | |
| 433 | 78.1B USD | 64 | 60 | |
| 433 | 838M EUR (≈$922M) | 64 | 71 | |
| 433 | 2.7B CAD (≈$2.0B) | 64 | 54 | |
| 433 | 4.0B USD | 64 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score